(19)
(11) EP 3 937 961 A1

(12)

(43) Date of publication:
19.01.2022 Bulletin 2022/03

(21) Application number: 20711172.5

(22) Date of filing: 16.03.2020
(51) International Patent Classification (IPC): 
A61K 35/766(2015.01)
(52) Cooperative Patent Classification (CPC):
C12N 2760/20243; C12N 2760/20222; C12N 15/86; C07K 14/005
(86) International application number:
PCT/EP2020/057144
(87) International publication number:
WO 2020/187850 (24.09.2020 Gazette 2020/39)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 15.03.2019 EP 19305317

(71) Applicants:
  • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    75016 Paris (FR)
  • Université Paris-Saclay
    91190 Gif-sur-Yvette (FR)

(72) Inventors:
  • ALBERTINI, Aurélie
    91940 GOMETZ LE CHATEL (FR)
  • RAUX, Hélène
    92160 ANTONY (FR)
  • GAUDIN, Yves
    75015 PARIS (FR)
  • PEREZ, Franck
    75013 PARIS (FR)

(74) Representative: Regimbeau 
20, rue de Chazelles
75847 Paris Cedex 17
75847 Paris Cedex 17 (FR)

   


(54) MUTANT VSV ECTODOMAIN POLYPEPTIDE AND USES THEREOF